Daytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5552-3.
Published March 29, 2023 · Recall initiated: March 10, 2023
Summary
FDA records drug Class II recall D-0470-2023, published March 29, 2023 and initiated March 10, 2023. Recalling firm: Noven Pharmaceuticals Inc; Status: Ongoing; Reported quantity: N/A; Lot: Lot#: 91955, Exp. 7/2023; 93039, Exp. 10/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Delivery System: Out of specification for shear.
What to do
Voluntary: Firm initiated · Letter
Get an email if DAYTRANA has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DAYTRANA
- Manufacturer
- Noven Pharmaceuticals Inc
- Distributor
- US Nationwide
- Lot
- Lot#: 91955, Exp. 7/2023; 93039, Exp. 10/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADaytrana (methylphenidate transdermal system) CII, 15 mg, 30-count carton, Rx only, Manufactured for NovenMarch 29, 2023
- FDADaytrana (methylphenidate transdermal system) CII, 20mg, 30-count carton, Rx only, Manufactured for NovenMarch 29, 2023
- FDADaytrana (methylphenidate transdermal system) CII, 30 mg, 30-count carton, Rx only, Manufactured for NovenMarch 29, 2023
- FDAJARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDCMarch 29, 2023
- FDAPatient Side Cart, REF: 380620, with instrument arms, used as part of the da Vinci X Surgical System, REF:March 22, 2023
- FDADaytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours, (1.6 mg/hr), 30 patches per box,December 7, 2022
Questions about this recall
Was Daytrana (methylphenidate transdermal system) CII, 10mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5552-3. recalled?
Yes. FDA published recall D-0470-2023 on March 29, 2023. Reported hazard: Defective Delivery System: Out of specification for shear.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DAYTRANA.